What is the feasibility of switching to 200IU OnabotulinumtoxinA in patients with detrusor overactivity who have previously received 300IU?

INTRODUCTION: To assess the feasibility of converting from 300IU to 200IU OnabotulinumtoxinA in patients diagnosed with either idiopathic detrusor overactivity (IDO) or neurogenic detrusor overactivity (NDO). MATERIAL AND METHODS: Retrospective case–notes review of patients who were converted from 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Malki, Manar, Mangera, Altaf, Reid, Sheilagh, Inman, Richard, Chapple, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074718/
https://www.ncbi.nlm.nih.gov/pubmed/24982778
http://dx.doi.org/10.5173/ceju.2014.01.art7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074718/
https://www.ncbi.nlm.nih.gov/pubmed/24982778
http://dx.doi.org/10.5173/ceju.2014.01.art7

Ejemplares similares